{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:56:11Z","timestamp":1790283371018,"version":"4.1.0"},"reference-count":242,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Type 1 diabetes (T1D) is characterized by the autoimmune destruction of insulin-producing \u03b2-cells in the pancreas. Regulatory T cells (Tregs) are essential for maintaining immune tolerance, but they manifest impaired functionality, particularly within the pancreatic microenvironment, during T1D development. This review aimed to discuss Treg biology including the developmental trajectory, phenotypic heterogeneity, and suppressive function, by which we sought to emphasize their compromised role in T1D pathogenesis associated with genetic\/epigenetic factors along with impaired cytokine signaling. The unique chemokine receptor expression signature, migratory capacity, and metabolic adaptation of pancreatic Tregs are highlighted, alongside insights from single-cell studies. The evolution of Treg-based immunotherapies is explored, with emphasis on genetically engineered Tregs (EngTregs), which are designed for the stable ectopic expression of FoxP3 and antigen-specific receptors, such as T cell receptors (TCR) or chimeric antigen receptors (CAR). It also highlights advancements in genome-editing and delivery technologies, along with rationally designed combination strategies incorporated into multifunctional cellular products. Despite encouraging preclinical results, significant challenges persist in clinical translation. Overall, this review synthesizes existing knowledge and outlines future directions in Treg biology and immunotherapy, underscoring the potential of next-generation Treg therapy to achieve durable immune tolerance in T1D.<\/jats:p>","DOI":"10.3389\/fendo.2025.1740102","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:18:21Z","timestamp":1767676701000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes"],"prefix":"10.3389","volume":"16","author":[{"given":"Kuang-Ji","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Jie","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Lin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147493","article-title":"The multifactorial progression from the islet autoimmunity to type 1 diabetes in children","volume":"22","author":"Bauer","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1326711","article-title":"Immunological and virological triggers of type 1 diabetes: insights and implications","volume":"14","author":"Lemos","year":"2023","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4942-x","article-title":"Early-life factors contributing to type 1 diabetes","volume":"62","author":"Craig","year":"2019","journal-title":"Diabetologia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.06.011","article-title":"Virus as the cause of type 1 diabetes","volume":"30","author":"Dahl-Jorgensen","year":"2024","journal-title":"Trends Mol Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.08.012","article-title":"Induced regulatory T cells: their development, stability, and applications","volume":"37","author":"Kanamori","year":"2016","journal-title":"Trends Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.728783","article-title":"Metabolic controls on epigenetic reprogramming in regulatory T cells","volume":"12","author":"Lu","year":"2021","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","volume":"30","author":"Ohkura","year":"2020","journal-title":"Cell Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01235","article-title":"Unique features of pancreatic-resident regulatory T cells in autoimmune type 1 diabetes","volume":"8","author":"Lu","year":"2017","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/dbi21-0036","article-title":"The beta-cell in type 1 diabetes pathogenesis: A victim of circumstances or an instigator of tragic events","volume":"71","author":"Mallone","year":"2022","journal-title":"Diabetes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01345","article-title":"Clostridium butyricum CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells","volume":"8","author":"Jia","year":"2017","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.coi.2017.10.002","article-title":"Molecular control of regulatory T cell development and function","volume":"49","author":"Kitagawa","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.immuni.2018.04.008","article-title":"Proteomic analyses of human regulatory T cells reveal adaptations in signaling pathways that protect cellular identity","volume":"48","author":"Cuadrado","year":"2018","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jaut.2017.07.009","article-title":"Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity","volume":"84","author":"Ferreira","year":"2017","journal-title":"J Autoimmun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1038\/s41467-021-24213-6","article-title":"Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human T(reg) compartment","volume":"12","author":"Luo","year":"2021","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2035117","DOI":"10.1080\/21645515.2022.2035117","article-title":"Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges","volume":"18","author":"Goswami","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.712870","article-title":"Antigen-specific treg therapy in type 1 diabetes - challenges and opportunities","volume":"12","author":"Serr","year":"2021","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1032575","article-title":"Type 1 regulatory T cell-mediated tolerance in health and disease","volume":"13","author":"Freeborn","year":"2022","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.12.003","article-title":"Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes","volume":"127","author":"Sanda","year":"2008","journal-title":"Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2337\/dbi18-0058","article-title":"Function, failure, and the future potential of tregs in type 1 diabetes","volume":"70","author":"Bettini","year":"2021","journal-title":"Diabetes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838105","article-title":"DNA methylation controls Foxp3 gene expression","volume":"38","author":"Polansky","year":"2008","journal-title":"Eur J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.09.010","article-title":"T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development","volume":"37","author":"Ohkura","year":"2012","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nature07674","article-title":"Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses","volume":"458","author":"Zheng","year":"2009","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151438","article-title":"Control of Foxp3 stability through modulation of TET activity","volume":"213","author":"Yue","year":"2016","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.07.031","article-title":"Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus","volume":"158","author":"Feng","year":"2014","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.07.030","article-title":"Function of a Foxp3 cis-element in protecting regulatory T cell identity","volume":"158","author":"Li","year":"2014","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737594","article-title":"DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells","volume":"37","author":"Baron","year":"2007","journal-title":"Eur J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.192.2.295","article-title":"Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation","volume":"192","author":"Read","year":"2000","journal-title":"J Exp Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nature16169","article-title":"Immune homeostasis enforced by co-localized effector and regulatory T cells","volume":"528","author":"Liu","year":"2015","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900691","article-title":"The initial phase of an immune response functions to activate regulatory T cells","volume":"183","author":"O\u2019Gorman","year":"2009","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711106105","article-title":"Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation","volume":"105","author":"Onishi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nri3108","article-title":"The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses","volume":"11","author":"Walker","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1292","article-title":"Detection of self-reactive CD8(+) T cells with an anergic phenotype in healthy individuals","volume":"346","author":"Maeda","year":"2014","journal-title":"Science"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1307185110","article-title":"Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression","volume":"110","author":"Yamaguchi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2011.10.002","article-title":"Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions","volume":"23","author":"Yamaguchi","year":"2011","journal-title":"Semin Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.958430","article-title":"Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children","volume":"13","author":"Starosz","year":"2022","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0213605","article-title":"Multiple immuno-regulatory defects in type-1 diabetes","volume":"109","author":"Kukreja","year":"2002","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1248","article-title":"No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes","volume":"56","author":"Brusko","year":"2007","journal-title":"Diabetes"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.1.92","article-title":"Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes","volume":"54","author":"Lindley","year":"2005","journal-title":"Diabetes"},{"key":"B57","doi-asserted-by":"publisher","first-page":"112724","DOI":"10.1016\/j.intimp.2024.112724","article-title":"Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence","volume":"140","author":"Huang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4377-1","article-title":"Regulatory T cell dysfunction in type 1 diabetes: what\u2019s broken and how can we fix it","volume":"60","author":"Hull","year":"2017","journal-title":"Diabetologia"},{"key":"B59","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/genes4030499","article-title":"Genes involved in type 1 diabetes: an update","volume":"4","author":"Bakay","year":"2013","journal-title":"Genes (Basel)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2009.84","article-title":"Overview of the type I diabetes genetics consortium","author":"Rich","year":"2009","journal-title":"Genes Immun"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100272","article-title":"Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function","volume":"188","author":"Garg","year":"2012","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2010.54","article-title":"An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells","volume":"12","author":"Long","year":"2011","journal-title":"Genes Immun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.2337\/db15-0516","article-title":"Natural variation in interleukin-2 sensitivity influences regulatory T-cell frequency and function in individuals with long-standing type 1 diabetes","volume":"64","author":"Yang","year":"2015","journal-title":"Diabetes"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0049","article-title":"Rapamycin\/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs beta-cell function","volume":"61","author":"Long","year":"2012","journal-title":"Diabetes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.immuni.2020.04.006","article-title":"Regulatory T cell-specific epigenomic region variants are a key determinant of susceptibility to common autoimmune diseases","volume":"52","author":"Ohkura","year":"2020","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003099","article-title":"Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes","volume":"186","author":"McClymont","year":"2011","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2015.43","article-title":"Treg activation defect in type 1 diabetes: correction with TNFR2 agonism","volume":"5","author":"Okubo","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.03.020","article-title":"Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency","volume":"36","author":"Bettini","year":"2012","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.03.016","article-title":"Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction","volume":"28","author":"Tang","year":"2008","journal-title":"Immunity"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0200","article-title":"CD4 T cells reactive to hybrid insulin peptides are indicators of disease activity in the NOD mouse","volume":"67","author":"Baker","year":"2018","journal-title":"Diabetes"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301600","article-title":"Reduced regulatory T cell diversity in NOD mice is linked to early events in the thymus","volume":"192","author":"Ferreira","year":"2014","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"356ra119","DOI":"10.1126\/scitranslmed.aad9943","article-title":"Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression","volume":"8","author":"Hundhausen","year":"2016","journal-title":"Sci Transl Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1774","article-title":"Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo","volume":"10","author":"Zhou","year":"2009","journal-title":"Nat Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special population of regulatory T cells potentiates muscle repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.021","article-title":"A distinct function of regulatory T cells in tissue protection","volume":"162","author":"Arpaia","year":"2015","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nature11132","article-title":"PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells","volume":"486","author":"Cipolletta","year":"2012","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nat Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2017.05.002","article-title":"Regulatory T cells in skin facilitate epithelial stem cell differentiation","volume":"169","author":"Ali","year":"2017","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.01.009","article-title":"Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells","volume":"44","author":"Kuswanto","year":"2016","journal-title":"Immunity"},{"key":"B81","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ni0515-544d","article-title":"Erratum: The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells","volume":"16","author":"Vasanthakumar","year":"2015","journal-title":"Nat Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa9420","article-title":"MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells","volume":"349","author":"Sefik","year":"2015","journal-title":"Science"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4263","article-title":"MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORgammat(+) T cells","volume":"349","author":"Ohnmacht","year":"2015","journal-title":"Science"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac5560","article-title":"Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine","volume":"351","author":"Kim","year":"2016","journal-title":"Science"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.703972","article-title":"Targeting mitochondrial-derived reactive oxygen species in T cell-mediated autoimmune diseases","volume":"12","author":"Ch\u00e1vez","year":"2021","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3577","article-title":"Foxp3 and Toll-like receptor signaling balance T(reg) cell anabolic metabolism for suppression","volume":"17","author":"Gerriets","year":"2016","journal-title":"Nat Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf2034","article-title":"Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissues","volume":"388","author":"Walker","year":"2025","journal-title":"Science"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1126\/science.1191996","article-title":"Stability of the regulatory T cell lineage in vivo","volume":"329","author":"Rubtsov","year":"2010","journal-title":"Science"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2009.05.007","article-title":"Plasticity of CD4(+) foxP3(+) T cells","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.016","article-title":"Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response","volume":"39","author":"Bailey-Bucktrout","year":"2013","journal-title":"Immunity"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12175","article-title":"Lineage stability and phenotypic plasticity of Foxp3(+) regulatory T cells","volume":"259","author":"Hori","year":"2014","journal-title":"Immunol Rev"},{"key":"B93","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s41038-015-0001-0","article-title":"Pathological conditions re-shape physiological Tregs into pathological Tregs","volume":"3","author":"Yang","year":"2015","journal-title":"Burns Trauma"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37865","article-title":"Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD\/SCID recipient mice","volume":"119","author":"Bending","year":"2009","journal-title":"J Clin Invest"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1415675112","article-title":"Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis","volume":"112","author":"Harbour","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901906","article-title":"Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes","volume":"183","author":"J\u00e4ger","year":"2009","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2008.11.005","article-title":"Late developmental plasticity in the T helper 17 lineage","volume":"30","author":"Lee","year":"2009","journal-title":"Immunity"},{"key":"B98","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1084\/jem.20071855","article-title":"Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors","volume":"205","author":"L\u00f6hning","year":"2008","journal-title":"J Exp Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502276","article-title":"Production of proinflammatory cytokines by monocytes in liver-transplanted recipients with de novo autoimmune hepatitis is enhanced and induces TH1-like regulatory T cells","volume":"196","author":"Arterbery","year":"2016","journal-title":"J Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2016.09.012","article-title":"IFN-gamma-producing Th1-like regulatory T cells may limit acute cellular renal allograft rejection: Paradoxical post-transplantation effects of IFN-gamma","volume":"222","author":"Xu","year":"2017","journal-title":"Immunobiology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.05.031","article-title":"T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor beta2","volume":"37","author":"Koch","year":"2012","journal-title":"Immunity"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/nature22360","article-title":"Stability and function of regulatory T cells expressing the transcription factor T-bet","volume":"546","author":"Levine","year":"2017","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1126\/science.1172702","article-title":"CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner","volume":"326","author":"Chaudhry","year":"2009","journal-title":"Science"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2426","article-title":"Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions","volume":"17","author":"Chung","year":"2011","journal-title":"Nat Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101328","article-title":"Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells","volume":"187","author":"Wollenberg","year":"2011","journal-title":"J Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2006","article-title":"The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells","volume":"12","author":"Cretney","year":"2011","journal-title":"Nat Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57456","article-title":"GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice","volume":"121","author":"Wohlfert","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00178","article-title":"Multiple treg suppressive modules and their adaptability","volume":"3","author":"Wing","year":"2012","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110428","article-title":"SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-gamma and IL-17A production","volume":"208","author":"Takahashi","year":"2011","journal-title":"J Exp Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.celrep.2018.09.016","article-title":"Blimp-1 functions as a molecular switch to prevent inflammatory activity in foxp3(+)RORgammat(+) regulatory T cells","volume":"25","author":"Ogawa","year":"2018","journal-title":"Cell Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1616710113","article-title":"Singular role for T-BET+CXCR3+ regulatory T cells in protection from autoimmune diabetes","volume":"113","author":"Tan","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040179","article-title":"CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion","volume":"199","author":"Herman","year":"2004","journal-title":"J Exp Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500703","article-title":"Phenotypic complexity of the human regulatory T cell compartment revealed by mass cytometry","volume":"195","author":"Mason","year":"2015","journal-title":"J Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2000037","article-title":"Transcriptomic profiling of human effector and regulatory T cell subsets identifies predictive population signatures","volume":"4","author":"Hollbacher","year":"2020","journal-title":"Immunohorizons"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"key":"B117","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","article-title":"Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation","volume":"50","author":"Miragaia","year":"2019","journal-title":"Immunity"},{"key":"B118","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2018.12.034","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"176","author":"Sade-Feldman","year":"2019","journal-title":"Cell"},{"key":"B119","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41590-018-0051-0","article-title":"Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR","volume":"19","author":"Zemmour","year":"2018","journal-title":"Nat Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"B121","doi-asserted-by":"publisher","first-page":"8894","DOI":"10.1038\/s41467-024-53264-8","article-title":"TGF-\u03b2-mediated crosstalk between TIGIT(+) Tregs and CD226(+)CD8(+) T cells in the progression and remission of type 1 diabetes","volume":"15","author":"Zhong","year":"2024","journal-title":"Nat Commun"},{"key":"B122","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41577-025-01149-2","article-title":"Regulatory T cell and endothelial cell crosstalk","volume":"25","author":"Piao","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2547-8","article-title":"Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice","volume":"55","author":"Yamada","year":"2012","journal-title":"Diabetologia"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.12.022","article-title":"Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response","volume":"30","author":"Zhang","year":"2009","journal-title":"Immunity"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2012.36","article-title":"Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and beta cell regeneration in a T1D model","volume":"9","author":"Nti","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.8.4730","article-title":"Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo","volume":"176","author":"Weber","year":"2006","journal-title":"J Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43048","article-title":"Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets","volume":"121","author":"Montane","year":"2011","journal-title":"J Clin Invest"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.46.10.1542","article-title":"Involvement of beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice","volume":"46","author":"Yang","year":"1997","journal-title":"Diabetes"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126311","article-title":"Th1-like ICOS+ Foxp3+ Treg cells preferentially express CXCR3 and home to \u03b2-islets during pre-diabetes in BDC2","volume":"10","author":"Kornete","year":"2015","journal-title":"5 NOD Mice. PloS One"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015070820","article-title":"T-bet enhances regulatory T cell fitness and directs control of th1 responses in crescentic GN","volume":"28","author":"Nosko","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00069","article-title":"T-bet expression by Foxp3(+) T regulatory cells is not essential for their suppressive function in CNS autoimmune disease or colitis","volume":"6","author":"McPherson","year":"2015","journal-title":"Front Immunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1084\/jem.20031819","article-title":"Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis","volume":"200","author":"Bettelli","year":"2004","journal-title":"J Exp Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/intimm\/dxh281","article-title":"Asthmatic changes in mice lacking T-bet are mediated by IL-13","volume":"17","author":"Finotto","year":"2005","journal-title":"Int Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011956","article-title":"The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn\u2019s disease","volume":"195","author":"Neurath","year":"2002","journal-title":"J Exp Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502537","article-title":"T-bet regulates natural regulatory T cell afferent lymphatic migration and suppressive function","volume":"196","author":"Xiong","year":"2016","journal-title":"J Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.34","article-title":"Emerging insights into natural killer cells in human peripheral tissues","volume":"16","author":"Bj\u00f6rkstr\u00f6m","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/372190a0","article-title":"Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin","volume":"372","author":"Cepek","year":"1994","journal-title":"Nature"},{"key":"B139","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-94-017-9153-3_7","article-title":"Integrin \u03b1E\u03b27: molecular features and functional significance in the immune system","volume":"819","author":"Hadley","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/ni1534","article-title":"The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics","volume":"9","author":"Ledgerwood","year":"2008","journal-title":"Nat Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/nature04606","article-title":"CD69 acts downstream of interferon-alpha\/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs","volume":"440","author":"Shiow","year":"2006","journal-title":"Nature"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116859","article-title":"Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium","volume":"92","author":"H\u00e4nninen","year":"1993","journal-title":"J Clin Invest"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1423769112","article-title":"Population dynamics of islet-infiltrating cells in autoimmune diabetes","volume":"112","author":"Magnuson","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0254-y","article-title":"The heterogeneous pathogenesis of type 1 diabetes mellitus","volume":"15","author":"Ilonen","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"10991","DOI":"10.1038\/ncomms10991","article-title":"Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice","volume":"7","author":"Serr","year":"2016","journal-title":"Nat Commun"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1068","article-title":"Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial\u2013Type 1","volume":"28","author":"Skyler","year":"2005","journal-title":"Diabetes Care"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02579-4","article-title":"Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabete Insuline Orale group","volume":"356","author":"Chaillous","year":"2000","journal-title":"Lancet"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.11.014","article-title":"A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells","volume":"30","author":"Yu","year":"2009","journal-title":"Immunity"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00654","article-title":"Inducing and administering tregs to treat human disease","volume":"6","author":"Perdigoto","year":"2015","journal-title":"Front Immunol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1126\/sciimmunol.aba5264","article-title":"An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice","volume":"5","author":"Khoryati","year":"2020","journal-title":"Sci Immunol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.4.2018","article-title":"IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells","volume":"178","author":"Zheng","year":"2007","journal-title":"J Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100209","article-title":"IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells","volume":"207","author":"Grinberg-Bleyer","year":"2010","journal-title":"J Exp Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0669","article-title":"beta-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice","volume":"62","author":"Johnson","year":"2013","journal-title":"Diabetes"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0070-2","article-title":"A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism","volume":"24","author":"Trotta","year":"2018","journal-title":"Nat Med"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"B157","doi-asserted-by":"publisher","first-page":"83ra41","DOI":"10.1126\/scitranslmed.3001809","article-title":"Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity","volume":"3","author":"Hippen","year":"2011","journal-title":"Sci Transl Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001278","article-title":"CD45RA distinguishes CD4+CD25+CD127-\/low TSDR demethylated regulatory T cell subpopulations with differential stability and susceptibility to tacrolimus-mediated inhibition of suppression","volume":"101","author":"Arroyo Hornero","year":"2017","journal-title":"Transplantation"},{"key":"B160","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","article-title":"Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up","volume":"153","author":"Marek-Trzonkowska","year":"2014","journal-title":"Clin Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00152","article-title":"Generation and function of induced regulatory T cells","volume":"4","author":"Schmitt","year":"2013","journal-title":"Front Immunol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"E198","DOI":"10.1371\/journal.pbio.0020198","article-title":"HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells","volume":"2","author":"Oswald-Richter","year":"2004","journal-title":"PloS Biol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/sj.mt.6300341","article-title":"Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3","volume":"16","author":"Allan","year":"2008","journal-title":"Mol Ther"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149210","article-title":"Towards gene therapy for IPEX syndrome","volume":"52","author":"Borna","year":"2022","journal-title":"Eur J Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay6422","article-title":"Gene editing to induce FOXP3 expression in human CD4(+) T cells leads to a stable regulatory phenotype and function","volume":"12","author":"Honaker","year":"2020","journal-title":"Sci Transl Med"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777788","article-title":"Using the T cell receptor as a biomarker in type 1 diabetes","volume":"12","author":"Nakayama","year":"2021","journal-title":"Front Immunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2019129118","article-title":"T-cell responses to hybrid insulin peptides prior to type 1 diabetes development","volume":"118","author":"Mitchell","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1015855","article-title":"Characterizing T cell responses to enzymatically modified beta cell neo-epitopes","volume":"13","author":"Nguyen","year":"2022","journal-title":"Front Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn1716","article-title":"Pancreatic islet-specific engineered T(regs) exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models","volume":"14","author":"Yang","year":"2022","journal-title":"Sci Transl Med"},{"key":"B170","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-018-0083-6","article-title":"Central CD4(+) T cell tolerance: deletion versus regulatory T cell differentiation","volume":"19","author":"Klein","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03650.x","article-title":"The potency of allospecific Tregs cells appears to correlate with T cell receptor functional avidity","volume":"11","author":"Tsang","year":"2011","journal-title":"Am J Transplant"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01313","article-title":"Avidity and bystander suppressive capacity of human regulatory T cells expressing de novo autoreactive T-cell receptors in type 1 diabetes","volume":"8","author":"Yeh","year":"2017","journal-title":"Front Immunol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700156","article-title":"Cutting edge: low-affinity TCRs support regulatory T cell function in autoimmunity","volume":"200","author":"Sprouse","year":"2018","journal-title":"J Immunol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1101\/2023.01.17.523999","article-title":"Increased TCR signaling in regulatory T cells is disengaged from TCR affinity","author":"Jing","year":"2023","journal-title":"bioRxiv"},{"key":"B175","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2017.01.001","article-title":"Generation of human islet-specific regulatory T cells by TCR gene transfer","volume":"79","author":"Hull","year":"2017","journal-title":"J Autoimmun"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1715590115","article-title":"Revealing the specificity of regulatory T cells in murine autoimmune diabetes","volume":"115","author":"Spence","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B177","unstructured":"Abata Therapeutics Announces Second Development Candidate, ABA-201, a novel Treg cell therapy for the treatment of type 1 diabetes\n          \n          Abata Therapeutics"},{"key":"B178","doi-asserted-by":"publisher","first-page":"104220","DOI":"10.1016\/j.cellimm.2020.104220","article-title":"Building a CAR-Treg: Going from the basic to the luxury model","volume":"358","author":"Rosado-S\u00e1nchez","year":"2020","journal-title":"Cell Immunol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz3866","article-title":"Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells","volume":"12","author":"Dawson","year":"2020","journal-title":"Sci Transl Med"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052302","article-title":"Synthetic immunology: hacking immune cells to expand their therapeutic capabilities","volume":"35","author":"Roybal","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxab052","article-title":"Engineering strategies for broad application of TCR-T- and CAR-T-cell therapies","volume":"33","author":"Watanabe","year":"2021","journal-title":"Int Immunol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01689","article-title":"TCR redirected T cells for cancer treatment: achievements, hurdles, and goals","volume":"11","author":"Manfredi","year":"2020","journal-title":"Front Immunol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","article-title":"The next generation of CRISPR-Cas technologies and applications","volume":"20","author":"Pickar-Oliver","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2015.10.014","article-title":"Origins of programmable nucleases for genome engineering","volume":"428","author":"Chandrasegaran","year":"2016","journal-title":"J Mol Biol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.10.004","article-title":"Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9","volume":"15","author":"Mandal","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1512503112","article-title":"Generation of knock-in primary human T cells using Cas9 ribonucleoproteins","volume":"112","author":"Schumann","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2017.143","article-title":"CRISPR\/Cas9 genome editing in human hematopoietic stem cells","volume":"13","author":"Bak","year":"2018","journal-title":"Nat Protoc"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761320","article-title":"CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell Malignancies","volume":"130","author":"Gomes-Silva","year":"2017","journal-title":"Blood"},{"key":"B192","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41598-017-00462-8","article-title":"CRISPR\/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells","volume":"7","author":"Rupp","year":"2017","journal-title":"Sci Rep"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1038\/nature13769","article-title":"Programmable RNA recognition and cleavage by CRISPR\/Cas9","volume":"516","author":"O\u2019Connell","year":"2014","journal-title":"Nature"},{"key":"B196","doi-asserted-by":"publisher","first-page":"aaf5573","DOI":"10.1126\/science.aaf5573","article-title":"C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector","volume":"353","author":"Abudayyeh","year":"2016","journal-title":"Science"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaq0180","article-title":"RNA editing with CRISPR-cas13","volume":"358","author":"Cox","year":"2017","journal-title":"Science"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2600","article-title":"RNA-guided gene activation by CRISPR-Cas9-based transcription factors","volume":"10","author":"Perez-Pinera","year":"2013","journal-title":"Nat Methods"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2598","article-title":"CRISPR RNA-guided activation of endogenous human genes","volume":"10","author":"Maeder","year":"2013","journal-title":"Nat Methods"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1021\/sb400081r","article-title":"Tunable and multifunctional eukaryotic transcription factors based on CRISPR\/Cas","volume":"2","author":"Farzadfard","year":"2013","journal-title":"ACS Synth Biol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10234","article-title":"CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter","volume":"7","author":"Choudhury","year":"2016","journal-title":"Oncotarget"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3199","article-title":"Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers","volume":"33","author":"Hilton","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2016.09.006","article-title":"Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing","volume":"167","author":"Amabile","year":"2016","journal-title":"Cell"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2016.01.008","article-title":"Rapamycin\/GABA combination treatment ameliorates diabetes in NOD mice","volume":"73","author":"He","year":"2016","journal-title":"Mol Immunol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0525","article-title":"Low-dose interleukin-2 combined with rapamycin led to an expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells and prolonged human islet allograft survival in humanized mice","volume":"69","author":"Hu","year":"2020","journal-title":"Diabetes"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.612737","article-title":"Tregs and mixed chimerism as approaches for tolerance induction in islet transplantation","volume":"11","author":"Pathak","year":"2020","journal-title":"Front Immunol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171844","article-title":"GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes","volume":"9","author":"Uenishi","year":"2024","journal-title":"JCI Insight"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35639","article-title":"Immunosuppression in islet transplantation","volume":"118","author":"Van Belle","year":"2008","journal-title":"J Clin Invest"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3246","article-title":"Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes","volume":"359","author":"Sockolosky","year":"2018","journal-title":"Science"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4478","article-title":"A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects","volume":"24","author":"Kagoya","year":"2018","journal-title":"Nat Med"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611638","article-title":"Super-treg: toward a new era of adoptive treg therapy enabled by genetic modifications","volume":"11","author":"Amini","year":"2020","journal-title":"Front Immunol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048934","article-title":"Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressive","volume":"51","author":"Mohseni","year":"2021","journal-title":"Eur J Immunol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9657","article-title":"Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity","volume":"8","author":"Scherlinger","year":"2022","journal-title":"Sci Adv"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90598","article-title":"Transplant trials with Tregs: perils and promises","volume":"127","author":"Tang","year":"2017","journal-title":"J Clin Invest"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxm151","article-title":"Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype","volume":"20","author":"Santner-Nanan","year":"2008","journal-title":"Int Immunol"},{"key":"B219","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"B220","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ajt.13456","article-title":"Discarded human thymus is a novel source of stable and long-lived therapeutic regulatory T cells","volume":"16","author":"Dijke","year":"2016","journal-title":"Am J Transplant"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2506549","article-title":"Stem cell\u2013derived, fully differentiated islets for type 1 diabetes","volume":"393","author":"Reichman","year":"2025","journal-title":"New Engl J Med"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.9.5845","article-title":"High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines","volume":"179","author":"Zhao","year":"2007","journal-title":"J Immunol"},{"key":"B223","doi-asserted-by":"publisher","first-page":"101250","DOI":"10.1016\/j.omtm.2024.101250","article-title":"CAR-T cell manufacturing landscape-Lessons from the past decade and considerations for early clinical development","volume":"32","author":"Dias","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B224","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1182\/blood-2021-154013","article-title":"Eight-day point of care CAR T-cell manufacturing on clinimacs prodigy from healthy donors as a proof-of-concept study","volume":"138","author":"Hankey","year":"2021","journal-title":"Blood"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0146-4_11","article-title":"CAR-T cell expansion in a xuri cell expansion system W25","volume":"2086","author":"Smith","year":"2020","journal-title":"Methods Mol Biol"},{"key":"B226","article-title":"Donation of starting material for advanced cell-based therapies. Department of Health and Social Care","year":"2014"},{"key":"B227","article-title":"ICMRA-ICH-IPRP-PICS joint work plan for harmonisation and convergence work to advance development of a regulatory pharmaceutical quality knowledge management capability","year":"2023"},{"key":"B228","article-title":"Considerations in developing a regulatory framework for human cells and tissues and for advance therapy medicinal products, Annex 3, TRS 1048","year":"2023"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14807","article-title":"Achievements and challenges of the Sakigake designation system in Japan","volume":"87","author":"Tanaka","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13536","article-title":"Conditional early approval for new drug applications in Japan: Current and emerging issues","volume":"16","author":"Tanaka","year":"2023","journal-title":"Clin Transl Sci"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"B232","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1038\/s41467-022-33656-4","article-title":"Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes","volume":"13","author":"Yuan","year":"2022","journal-title":"Nat Commun"},{"key":"B233","doi-asserted-by":"publisher","first-page":"114763","DOI":"10.1016\/j.biopha.2023.114763","article-title":"Short chain fatty acids, a possible treatment option for autoimmune diseases","volume":"163","author":"Golpour","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B234","doi-asserted-by":"publisher","first-page":"100762","DOI":"10.1016\/j.xcrm.2022.100762","article-title":"Dysregulation of secondary bile acid metabolism precedes islet autoimmunity and type 1 diabetes","volume":"3","author":"Lamichhane","year":"2022","journal-title":"Cell Rep Med"},{"key":"B235","doi-asserted-by":"publisher","first-page":"102130","DOI":"10.1016\/j.xcrm.2025.102130","article-title":"Restoration of intestinal secondary bile acid synthesis: A potential approach to improve pancreatic beta cell function in type 1 diabetes","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep Med"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0620-2","article-title":"The human gut microbiome in early-onset type 1 diabetes from the TEDDY study","volume":"562","author":"Vatanen","year":"2018","journal-title":"Nature"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00561","article-title":"The bile acid TUDCA improves beta-cell mass and reduces insulin degradation in mice with early-stage of type-1 diabetes","volume":"10","author":"Bronczek","year":"2019","journal-title":"Front Physiol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-019-00684-8","article-title":"Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening","volume":"11","author":"Zhang","year":"2020","journal-title":"Protein Cell"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3646","article-title":"Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment","volume":"18","author":"Kitagawa","year":"2017","journal-title":"Nat Immunol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaut.2019.02.007","article-title":"Impaired Tip60-mediated Foxp3 acetylation attenuates regulatory T cell development in rheumatoid arthritis","volume":"100","author":"Su","year":"2019","journal-title":"J Autoimmun"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1126\/science.1176077","article-title":"Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells","volume":"325","author":"Pan","year":"2009","journal-title":"Science"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2868","article-title":"Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells","volume":"15","author":"Arvey","year":"2014","journal-title":"Nat Immunol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1740102\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:18:23Z","timestamp":1767676703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1740102\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":242,"alternative-id":["10.3389\/fendo.2025.1740102"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1740102","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"article-number":"1740102"}}